dihydroxyphenylalanine has been researched along with pridopidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barlow, KB; Johansson, AM; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE; Svensson, KA | 1 |
Kullingsjö, J; Lagerkvist, S; Martin, P; Pettersson, F; Ponten, H; Sonesson, C; Waters, N; Waters, S | 1 |
2 other study(ies) available for dihydroxyphenylalanine and pridopidine
Article | Year |
---|---|
The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor sid
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Binding, Competitive; Dihydroxyphenylalanine; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Immunohistochemistry; Male; Motor Activity; Neostriatum; Nucleus Accumbens; Piperidines; Prolactin; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reserpine | 2006 |
In vivo pharmacology of the dopaminergic stabilizer pridopidine.
Topics: Animals; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mice; Microdialysis; Motor Activity; Norepinephrine; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2010 |